• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射部位出现类似狼疮的干扰素反应:5例报告

Lupus-like reaction to interferon at the injection site: report of five cases.

作者信息

Arrue Itziar, Saiz Ana, Ortiz-Romero Pablo Luis, Rodríguez-Peralto José Luis

机构信息

Department of Dermatology, University Hospital, Madrid, Spain.

出版信息

J Cutan Pathol. 2007 Dec;34 Suppl 1:18-21. doi: 10.1111/j.1600-0560.2007.00715.x.

DOI:10.1111/j.1600-0560.2007.00715.x
PMID:17997732
Abstract

BACKGROUND

Interferon therapy at the injection sites has been related to different cutaneous lesions including erythema and induration as the most frequent ones. While the glycoprotein induces fatigue, fever and is even believed to precipitate autoimmune disorders such as type I diabetes, thyroid disease and systemic lupus erythematosus, a lupus erythematosus-like histologic reaction at the interferon injection site has never been reported. To our knowledge, a microscopic self-resolving lesion mimicking lupus erythematosus at the injection site of interferon has not been described.

RESULTS

We report five cases of cutaneous lesions at the inoculation site of interferon with a histopathologic lupus erythematosus-like pattern. Three of them were receiving interferon alfa therapy because of a malignant melanoma and the other two patients were receiving interferon beta-1b for multiple sclerosis. Biopsy specimens taken from different lesions showed similar microscopic findings consisting of dermal mucin deposits and dense lymphocytic infiltrates along hair follicles with hydropic degeneration of follicular basal layer.

CONCLUSIONS

Multiple cutaneous lesions related to interferon at the injection site have been reported, but none of them with a histologic lupus-like presentation. In this study we describe five cases in which interferon therapy has induced a resolutive cutaneous lesion mimicking lupus erythematous. This peculiar microscopic pattern has been previously described once before, but interpreted as cutaneous mucinosis.

摘要

背景

干扰素治疗在注射部位与不同的皮肤病变有关,其中最常见的是红斑和硬结。虽然这种糖蛋白会导致疲劳、发热,甚至被认为会引发自身免疫性疾病,如I型糖尿病、甲状腺疾病和系统性红斑狼疮,但从未有过在干扰素注射部位出现类似红斑狼疮的组织学反应的报道。据我们所知,尚未描述过在干扰素注射部位出现类似红斑狼疮的微观自限性病变。

结果

我们报告了5例在干扰素接种部位出现的皮肤病变,其组织病理学表现为类似红斑狼疮的模式。其中3例因恶性黑色素瘤接受干扰素α治疗,另外2例因多发性硬化症接受干扰素β-1b治疗。从不同病变部位采集的活检标本显示出相似的微观表现,包括真皮粘蛋白沉积以及沿毛囊的密集淋巴细胞浸润,同时伴有毛囊基底层的水样变性。

结论

此前已报道过与干扰素相关的注射部位多发性皮肤病变,但均无类似狼疮的组织学表现。在本研究中,我们描述了5例干扰素治疗诱发类似红斑狼疮的自限性皮肤病变的病例。这种独特的微观模式此前曾被描述过一次,但被解释为皮肤粘蛋白病。

相似文献

1
Lupus-like reaction to interferon at the injection site: report of five cases.注射部位出现类似狼疮的干扰素反应:5例报告
J Cutan Pathol. 2007 Dec;34 Suppl 1:18-21. doi: 10.1111/j.1600-0560.2007.00715.x.
2
A lupus-like reaction to subcutaneous interferon-α at injection sites.皮下注射干扰素-α后注射部位出现狼疮样反应。
J Drugs Dermatol. 2012 Mar;11(3):393-8.
3
Interferon-beta injection site reaction: review of the histology and report of a lupus-like pattern.β-干扰素注射部位反应:组织学回顾及狼疮样模式报告
J Am Acad Dermatol. 2008 Aug;59(2 Suppl 1):S48-9. doi: 10.1016/j.jaad.2007.12.013.
4
Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.多发性硬化症患者中干扰素β-1b的严重局部皮肤反应——通过皮下深层注射改善
Eur J Dermatol. 2008 Sep-Oct;18(5):579-82. doi: 10.1684/ejd.2008.0494. Epub 2008 Aug 8.
5
[Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection].[广泛皮肤-皮下浸润作为β-干扰素注射的一种副作用]
Hautarzt. 1998 Apr;49(4):310-2. doi: 10.1007/s001050050747.
6
Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review.表现为非典型痤疮样和粉刺样斑块的慢性皮肤型红斑狼疮:病例报告及文献综述
Lupus. 2018 Apr;27(5):853-857. doi: 10.1177/0961203317726377. Epub 2017 Aug 31.
7
Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta-1b injection for multiple sclerosis treatment.皮肤坏死性病变:多发性硬化症治疗中干扰素 β-1b 注射的奇妙延迟不良反应。
J Cosmet Dermatol. 2020 Apr;19(4):951-953. doi: 10.1111/jocd.13104. Epub 2019 Aug 22.
8
Drug-induced subacute cutaneous lupus erythematosus due to treatment with interferon beta-1a.
N Z Med J. 2013 Aug 2;126(1379):98-101.
9
Delayed occurrence of a severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b.一名服用β-1b干扰素的多发性硬化症患者出现严重皮肤反应的延迟发作。
Allergy Asthma Proc. 1998 Mar-Apr;19(2):85-8. doi: 10.2500/108854188778607200.
10
A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.红斑狼疮样中毒性表皮坏死松解症 1 例并文献复习
Lupus. 2013 Jul;22(8):839-46. doi: 10.1177/0961203313492242. Epub 2013 Jun 11.

引用本文的文献

1
Injection Site Bullous Eruption and Generalized Rash Induced by Pegylated Interferon Treatment for Hepatitis C.聚乙二醇干扰素治疗丙型肝炎所致注射部位大疱性皮疹及全身性皮疹
Gastroenterol Hepatol (N Y). 2009 Oct;5(10):715-718.
2
A Case Report of a Cutaneous Mucinous Reaction Associated with Erlotinib Therapy Used in the Treatment of Metastatic Tonsillar Sinus Squamous Cell Carcinoma.厄洛替尼治疗转移性扁桃体窦鳞状细胞癌相关皮肤黏液性反应1例报告
J Immunother Precis Oncol. 2019 Dec 13;3(1):31-33. doi: 10.4103/JIPO.JIPO_21_19. eCollection 2020 Feb.
3
Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
选择性 Janus 激酶 1 抑制是治疗红斑狼疮皮肤损伤的一种有前途的治疗方法。
Front Immunol. 2020 Mar 3;11:344. doi: 10.3389/fimmu.2020.00344. eCollection 2020.
4
Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis.在治疗多发性硬化症时,疾病修饰疗法引发或加重其他免疫介导疾病。
Iran J Neurol. 2018 Jul 6;17(3):129-136.
5
Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.肿瘤坏死因子抑制剂的药物安全性和免疫原性:迄今为止的故事。
Rheumatology (Oxford). 2018 Nov 1;57(11):1896-1907. doi: 10.1093/rheumatology/kex434.
6
Lupus erythematosus revisited.红斑狼疮再探讨。
Semin Immunopathol. 2016 Jan;38(1):97-112. doi: 10.1007/s00281-015-0550-0. Epub 2015 Dec 4.
7
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.与干扰素-β治疗多发性硬化症相关的皮肤不良事件
Int J Mol Sci. 2015 Jul 2;16(7):14951-60. doi: 10.3390/ijms160714951.
8
Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.红斑狼疮发病机制中的光敏感性、细胞凋亡和细胞因子:批判性回顾。
Clin Rev Allergy Immunol. 2014 Oct;47(2):148-62. doi: 10.1007/s12016-013-8403-x.
9
Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.系统性红斑狼疮中I型干扰素途径的激活:与不同临床表型的关联
J Biomed Biotechnol. 2011;2011:273907. doi: 10.1155/2011/273907. Epub 2011 Nov 16.
10
A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.使用干扰素和利巴韦林引起的皮肤药物不良反应综述。
Can J Gastroenterol. 2009 Oct;23(10):677-83. doi: 10.1155/2009/651952.